In the South Australian grain belt, solar-powered sensors the size of small refrigerators stand sentinel in fields, quietly inhaling the air. Every minute, they pull in about 10 liters, trapping whatever floats by on sticky tape. High-resolution cameras peer at the catch, and algorithms trained to recognize trouble scan for fungal spores—the kind that can wipe out a wheat crop before a farmer even knows there's a problem.
This is BioScout's pitch: real-time disease surveillance for agriculture, delivered to a grower's phone before symptoms appear in the field.
The Sydney-based startup has been steadily accumulating the sort of backers that signal something more than venture capital enthusiasm. GrainCorp Ventures, the investment arm of one of Australia's largest grain companies, took an undisclosed minority stake in November 2024. The Hort Innovation Venture Fund—representing levy-paying horticulture growers across Australia—made BioScout its inaugural investment in 2025. Earlier support came from North American agriculture investors and university-linked venture funds, though the company has been selective about disclosing exact figures beyond its AU$3 million seed round in June 2022.
The investor roster spans three continents, which is notable for an agtech company still in its commercialization phase. It suggests confidence in BioScout's approach to a problem that has bedeviled farmers for generations: detecting disease early enough to matter.
The Grower's Dilemma
Fungal diseases are estimated to destroy somewhere between 20 and 40 percent of global food production each year, according to industry research. For growers, the calculus is brutal. Spray preventatively and you're spending money on chemicals you might not need. Wait for visible symptoms and you've likely waited too long—infection has already established, yields are compromised, and treatment becomes damage control rather than prevention.
Traditional monitoring hasn't changed much in decades. Visual scouting is labor-intensive and often reactive. Passive spore traps require laboratory analysis, creating detection lags that undermine treatment timing. BioScout's founders—Lewis Collins, Saron Berhane, Henry Brindle, and Josh Wilson, all University of Sydney graduates—saw an opening for automation.
Collins, who studied mechatronics and biomedical engineering, leads the company as CEO. The team, which has grown to approximately 36 people working from Marrickville in Sydney's inner west, spun out of the university in 2019 with technology that essentially marries microscopy, artificial intelligence, and field connectivity.
The system they've built deploys sensors that continuously sample air, capturing fungal spores on tape. AI classification algorithms identify pathogens down to roughly 2 micrometers in size, then transmit results to growers via 4G networks. It's not revolutionary science, exactly—more an engineering problem of making the components robust enough for field deployment and accurate enough to be useful.
Scale, Slowly
During the 2024 season, BioScout deployed approximately 60 sensors across South Australia, Western Australia, Victoria, and New South Wales in partnership with the Grains Research and Development Corporation, or GRDC. According to a GRDC report from February 2025, the network sampled close to 1 billion liters of air and tracked roughly 1.6 million spores.
Those numbers sound impressive until you consider the scale of Australian grain production. The real test is whether growers find the data actionable—and worth paying for once research partnerships transition to commercial subscriptions.
GrainCorp's involvement carries weight beyond the capital injection. The company's operational footprint across Australian grain supply chains offers BioScout something venture money can't buy: direct access to growers and agronomic expertise at commercial scale. That relationship could prove more valuable than the funding itself, particularly as BioScout attempts to shift from trials to revenue.
The Hort Innovation Venture Fund's decision to make BioScout its first-ever portfolio company signals credibility within the horticulture sector. Hort Innovation is funded by grower levies, so the investment represents a vote of confidence from the industry itself—though perhaps also pressure to deliver results that justify the faith.
North American Ambitions
BioScout's North American expansion began in May 2023, when the Global Agri-Food Advancement Partnership—a Saskatchewan-based investment group—led a funding round that enabled establishment of a Saskatoon office. The Saskatchewan connection is strategic. The region already has crop disease monitoring networks, but they rely largely on manual or passive detection methods that BioScout aims to leapfrog.
Field trials have since extended to Manitoba, where EMILI Innovation Farms tested the system for early disease warning in potato crops. It's a push into horticulture beyond BioScout's initial grain focus, expanding the addressable market but also the complexity. Different crops mean different pathogens, which means expanding the AI's training libraries and validating accuracy across new contexts.
The competitive landscape isn't crowded, but it's not empty either. California-based Scanit Technologies launched the Iowa SporeWarn Network in mid-2026 for autonomous airborne pathogen detection. Established passive monitoring systems like Spornado traps are used across Canadian late blight networks. BioScout's advantage may be less about being first and more about execution—can they make the technology reliable and affordable enough for widespread adoption?
The Funding Mix
Beyond investor capital, BioScout has tapped government support. The Australian Government's Entrepreneurs' Programme approved AU$716,005 through its Accelerating Commercialisation grant in May 2022. The NSW Physical Sciences Fund contributed AU$627,000. These aren't trivial amounts for a startup still proving commercial viability, and they reflect the kind of patient, risk-tolerant capital that agtech often requires.
Partners now include Queensland's Department of Agriculture and Fisheries, Elders Rural Services, Pairtree Intelligence, Western Australia's Department of Primary Industries and Regional Development, and South Australia's SARDI. The company also serves viticulture and orchard operations—sectors where fungal diseases drive repeated fungicide applications and margins can support technology adoption.
What Success Looks Like
BioScout's investor mix positions the company across multiple segments: grain, horticulture, viticulture. Each brings different challenges. GrainCorp Ventures provides grain industry integration. Hort Innovation offers horticulture sector credibility. The Global Agri-Food Advancement Partnership brings North American market access.
The question, as with most agtech, is whether the value proposition pencils out for growers. Early disease detection has obvious appeal, but farmers operate on thin margins and have learned to be skeptical of technology promises. BioScout needs to prove not just that the sensors work, but that they deliver economic returns that justify the cost—and perhaps more importantly, that they reduce chemical inputs without sacrificing yields.
That's a harder sell than simply detecting spores, and it's where many agtech companies stumble. The technology might be sound, but if the business model doesn't align with how growers actually make purchasing decisions, even the best sensors end up as expensive lawn ornaments.
For now, BioScout appears to be executing the slow, unglamorous work of building partnerships, expanding pathogen libraries, and deploying more sensors. It's not the kind of hypergrowth story that makes venture capitalists salivate, but in agriculture—where adoption cycles are measured in seasons and trust is earned incrementally—maybe that's exactly the right approach.
